United States

People: Quintiles IMS Holdings Inc (Q.N)

Q.N on New York Stock Exchange

12:52pm EDT
Change (% chg)

$-0.12 (-0.13%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gillings, Dennis 

Dr. Dennis B. Gillings, CBE, Ph.D. is Director of the Company. He has served as a director since he founded our Company in 1982 and served as our Executive Chairman until December 31, 2015. He also served as our Chief Executive Officer from 1982 to December 2012. Dr. Gillings taught for more than 15 years as a professor at the University of North Carolina at Chapel Hill. Dr. Gillings serves on several other boards and councils, including the International Advisory Council to Singapore, the International Advisory Board for the Scottish Enterprise, and the Advisory Board of the Schaeffer Health Policy Institute at the University of Southern California. He served as the founding Chairman of the Association of Clinical Research Organizations, a Washington-based trade group formed in 2002. He also served as a director of Icagen, Inc., a biopharmaceutical company, from 1997 until June 2011. He was awarded the Commander in The Most Excellent Order of the British Empire in 2004. Dr. Gillings served as Pro Chancellor of the University of Southampton from 2006 to 2011. In 2012, he received the SCRIP Lifetime Achievement Award in recognition of contributions to the pharmaceutical industry. Dr. Gillings received a diploma in Mathematical Statistics from Cambridge University in 1967 and a Ph.D. in Mathematics from the University of Exeter, England, in 1972. During 1996 to 1997, Dr. Gillings received honorary Professorships of Medicine from Beijing University, Peking Union Medical College, Shanghai University and Xian University. Dr. Gillings has also received Honorary Doctorate degrees from the University of Exeter, the University of North Carolina at Chapel Hill, the University of Southampton, Kings College London, and University College London. In 2008, he became an Honorary Fellow at Queen Mary, University of London, and the Academy of Medical Science, London.

Basic Compensation

Total Annual Compensation, USD 800,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 822,195
Fiscal Year Total, USD 1,622,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 1,000,000 50,380,000.00